Latest Asx Companies News

Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.

Mayfield Group Holdings has declared a $5 million special dividend alongside its interim payout, signaling robust financial health and confidence in sustained growth.

Latrobe Magnesium Limited has responded to an ASX price query, denying any undisclosed information that could explain the recent sharp drop in its share price and surge in trading volume.